Celebrating MG Awareness Month, Together From Afar

 
Although this June may look and feel different from years past, we’re just as excited to spread awareness together with the myasthenia gravis (MG) community in celebration of Myasthenia Gravis (MG) Awareness Month. In light of the impact coronavirus is having on people around the world, especially people with MG who may be immunocompromised, we’re looking forward to connecting and celebrating in a virtual way.  

According to a study conducted by the Myasthenia Gravis Foundation of America (MGFA), this chronic, autoimmune condition can impact a person’s life in many ways. MG is a neuromuscular condition that causes the body’s immune system to mistakenly target the connection between the nerves and muscles, resulting in symptoms such as drooping eyelids and double vision, as well as severe muscular weakness that can result in life-threatening failure of the muscles that help with swallowing and respiration. For those affected, these MG symptoms can regularly interfere with aspects of everyday life.

At UCB, we are always focused on delivering value for the patient populations we serve. Last month, UCB finalized the acquisition of Ra Pharmaceuticals, a move that helps strengthen our neurology and immunology efforts and advances our progress in treating a broad population of people living with MG. Our newly expanded portfolio allows us to expand our research capabilities, accelerate development of new medicines and hopefully make a bigger impact within the MG community.

We hope you will join us in virtually celebrating MG Awareness Month. Consider taking part in raising awareness and empowering the MG community by supporting the activities of the MG community in your country or sharing your own experiences via social media.

For more information and resources about MG, read our infographic here or visit myasthenia.org.